Cargando…

Extracellular vesicles produced by immunomodulatory cells harboring OX40 ligand and 4-1BB ligand enhance antitumor immunity

Genetically modified tumor cells harboring immunomodulators may be used as therapeutic vaccines to stimulate antitumor immunity. The therapeutic benefit of these tumor vaccines is extensively investigated and mechanisms by which they boost antitumor response may be further explored. Tumor cells are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Semionatto, Isadora Ferraz, Palameta, Soledad, Toscaro, Jéssica Marcelino, Manrique-Rincón, Andrea Johanna, Ruas, Luciana Pereira, Paes Leme, Adriana Franco, Bajgelman, Marcio Chaim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495001/ https://www.ncbi.nlm.nih.gov/pubmed/32939048 http://dx.doi.org/10.1038/s41598-020-72122-3

Ejemplares similares

Boosting antitumor response with PSMA-targeted immunomodulatory VLPs, harboring costimulatory TNFSF ligands and GM-CSF cytokine
por: Palameta, Soledad, et al.
Publicado: (2022)

Boosting Antitumor Response by Costimulatory Strategies Driven to 4-1BB and OX40 T-cell Receptors
por: Mascarelli, Daniele E., et al.
Publicado: (2021)

Exploring Synergy in Combinations of Tumor-Derived Vaccines That Harbor 4-1BBL, OX40L, and GM-CSF
por: Manrique-Rincón, Andrea J., et al.
Publicado: (2017)

Multimeric forms of CD40 ligand (CD40L), 4-1BB ligand (4-1BBL), OX40 ligand (OX40L), CD27L/CD70, and other TNFSFs as tools for adoptive cell therapy
por: Kornbluth, Richard S
Publicado: (2013)

OX40/OX40 Ligand Interactions in T-Cell Regulation and Asthma
por: Kaur, Davinder, et al.
Publicado: (2012)

Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome
por: Kawana, Yuki, et al.
Publicado: (2021)

Expression of gp34 (OX40 Ligand) and OX40 on Human T Cell Clones
por: Takasawa, Naruhiko, et al.
Publicado: (2001)

Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia
por: Cui, Dawei, et al.
Publicado: (2019)

OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer
por: Deng, Juan, et al.
Publicado: (2019)

SCHOOL of nature: ligand-independent immunomodulatory peptides
por: Sigalov, Alexander B.
Publicado: (2020)

Aptamer-mediated transcriptional gene silencing of Foxp3 inhibits regulatory T cells and potentiates antitumor response
por: Manrique-Rincón, Andrea J., et al.
Publicado: (2021)

Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis
por: Zhou, Xiaoling, et al.
Publicado: (2022)

Immunostimulation by OX40 Ligand Transgenic Ewing Sarcoma Cells
por: Reuter, Dajana, et al.
Publicado: (2015)

OX40 ligand expression abrogates the immunosuppressive function of retinal pigment epithelium
por: Cunningham, Matthew A, et al.
Publicado: (2013)

OX40 and 4-1BB delineate distinct immune profiles in sarcoma
por: Melake, MJ, et al.
Publicado: (2022)

Serotoninergic Modulation of Basal Cardiovascular Responses and Responses Induced by Isotonic Extracellular Volume Expansion in Rats
por: Semionatto, Isadora Ferraz, et al.
Publicado: (2017)

Impairment of Antigen-Presenting Cell Function in Mice Lacking Expression of Ox40 Ligand
por: Murata, Kazuko, et al.
Publicado: (2000)

Screening for PPAR Non-Agonist Ligands Followed by Characterization of a Hit, AM-879, with Additional No-Adipogenic and cdk5-Mediated Phosphorylation Inhibition Properties
por: Ribeiro Filho, Helder Veras, et al.
Publicado: (2018)

Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
por: Ylösmäki, Erkko, et al.
Publicado: (2021)

CD28-independent, TRAF2-dependent Costimulation of Resting T Cells by 4-1BB Ligand
por: Saoulli, Katina, et al.
Publicado: (1998)

Immunomodulatory Response of Toll-like Receptor Ligand–Peptide Conjugates in Food Allergy
por: Losada Méndez, Jorge, et al.
Publicado: (2021)

Critical Contribution of Ox40 Ligand to T Helper Cell Type 2 Differentiation in Experimental Leishmaniasis
por: Akiba, Hisaya, et al.
Publicado: (2000)

Activation of OX40 and CD27 Costimulatory Signalling in Sheep through Recombinant Ovine Ligands
por: Rojas, José Manuel, et al.
Publicado: (2020)

High serum OX40 ligand correlates with severity and mortality in patients with massive cerebral infarction
por: Mao, Lun-Lin, et al.
Publicado: (2020)

The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells
Publicado: (1991)

The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses
por: Barao, Isabel
Publicado: (2013)

Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression
por: Chen, Chider, et al.
Publicado: (2014)

Identification of serum glycoprotein ligands for the immunomodulatory receptor blood dendritic cell antigen 2
por: Kim, Jong-won, et al.
Publicado: (2018)

P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine
por: Liu, J, et al.
Publicado: (2009)

OX40 ligand newly expressed on bronchiolar progenitors mediates influenza infection and further exacerbates pneumonia
por: Hirano, Taizou, et al.
Publicado: (2016)

Model for predicting age-dependent safety and immunomodulatory effects of STING ligands in non-human primates
por: Takahama, Shokichi, et al.
Publicado: (2022)

OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy
por: Shibahara, Ichiyo, et al.
Publicado: (2015)

24: ASSOCIATION OF RS3850641 POLYMORPHISM IN OX40 LIGAND GENE AND PREMATURE MYOCARDIAL INFARCTION, SOUTHERN OF IRAN
por: Rahmanian, Zhila, et al.
Publicado: (2017)

TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand
por: Pattarini, Lucia, et al.
Publicado: (2017)

Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP
Publicado: (1995)

Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer
por: Trüb, Marta, et al.
Publicado: (2020)

Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15
por: McArdel, Shannon L., et al.
Publicado: (2021)

Dectin-1 plays a redundant role in the immunomodulatory activities of β-glucan-rich ligands in vivo
por: Marakalala, Mohlopheni J., et al.
Publicado: (2013)

Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
por: Gonçalves, Elaine C. D., et al.
Publicado: (2020)

Low expression of angiotensinogen and dipeptidyl peptidase 1 in saliva of patients with proliferative verrucous leukoplakia
por: Flores, Isadora Luana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eiccnl5uj4sgk7tfis1139ved0